Machine Learning

As AI data centers grow more complex, a new wave of intelligent management tools emerges. KAYTUS's KSManage promises to shift from reactive fixes to predictive foresight.

A novel mouse model with human immune receptors promises to slash the high failure rate of antibody therapies, accelerating life-saving treatments.

Huawei's new AI Calling solution promises real-time translation and smart assistants, but can global networks and privacy standards keep up with innovation?

With a record $411M backlog and surging revenue, Redwire's strategic pivot to defense and space comes at a high cost. Can it turn growth into profit?

With a massive late-stage pipeline and deep pockets, the biotech aims to defeat elusive cancer targets, but soaring costs raise the stakes for pivotal trials.

The diagnostics firm beat Q4 estimates with a 705% profit jump, driven by its Decipher and Afirma tests, and plans to launch two new products in 2026.

With cash to last until 2027 but mounting losses, Alector stakes its future on its ABC platform and a pivotal Alzheimer's trial milestone.

Quantum firm IonQ shatters revenue goals with $130M in 2025 and moves to acquire a chip foundry, signaling an aggressive push to own the quantum stack.

Y Combinator-backed Coinrule now offers AI-driven trading for stocks and ETFs, entering a competitive market under the watchful eye of regulators.

A landmark summit in New Delhi launches a strategic tech partnership, aiming to build a sovereign 'third way' in AI and challenge global power dynamics.

A new venture plans to transform Los Angeles's legacy oil fields into clean power plants for the AI industry, bypassing an already strained energy grid.

Valant's AI Notes Assist now supports 100+ templates, aiming to reduce clinician burnout by fitting into existing workflows, not forcing new ones.

A new alliance aims to solve the GPU utilization puzzle, offering a standardized path for neoclouds to build high-performance AI infrastructure.

A nonprofit is investing millions in a novel program to fast-track academic breakthroughs for neurological diseases from the lab to patients.

At MWC 2026, IP Infusion launched OcNOS 7.0, targeting AI data centers and 400G/800G optical transport with an open, cost-saving platform.

IMO Health integrates a global rare disease database into EHRs, promising to shorten diagnosis times and accelerate vital research for millions.

A new partnership in the Carolinas is creating a vital material for AI chips, aiming to strengthen US tech independence and secure the semiconductor supply chain.

The sports betting aggregator launches AtlasDFS, an integrated Pick'em game, aiming to become an all-in-one hub for fans amid fierce regulatory headwinds.

One River Asset Management acquires LGT's quant team and $900M+ in strategies, establishing a Swiss base and bolstering its systematic risk offerings.

Amid a surge in MedTech M&A, Piper Sandler appoints 25-year veteran Aamer Naseer to steer its life sciences outsourcing and B2B technology groups.